nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Bexarotene—hematologic cancer	0.048	0.0829	CbGbCtD
Desvenlafaxine—CYP3A4—Lomustine—hematologic cancer	0.0447	0.0771	CbGbCtD
Desvenlafaxine—CYP3A4—Busulfan—hematologic cancer	0.0447	0.0771	CbGbCtD
Desvenlafaxine—CYP3A4—Thiotepa—hematologic cancer	0.0398	0.0687	CbGbCtD
Desvenlafaxine—CYP3A4—Methoxsalen—hematologic cancer	0.031	0.0534	CbGbCtD
Desvenlafaxine—CYP3A4—Bortezomib—hematologic cancer	0.0294	0.0508	CbGbCtD
Desvenlafaxine—CYP3A4—Daunorubicin—hematologic cancer	0.0282	0.0486	CbGbCtD
Desvenlafaxine—CYP3A4—Cytarabine—hematologic cancer	0.0248	0.0429	CbGbCtD
Desvenlafaxine—CYP3A4—Teniposide—hematologic cancer	0.0245	0.0422	CbGbCtD
Desvenlafaxine—CYP3A4—Ifosfamide—hematologic cancer	0.0226	0.039	CbGbCtD
Desvenlafaxine—CYP3A4—Imatinib—hematologic cancer	0.0216	0.0372	CbGbCtD
Desvenlafaxine—CYP3A4—Ruxolitinib—hematologic cancer	0.0203	0.0351	CbGbCtD
Desvenlafaxine—CYP3A4—Nilotinib—hematologic cancer	0.0196	0.0338	CbGbCtD
Desvenlafaxine—CYP3A4—Vinorelbine—hematologic cancer	0.0194	0.0335	CbGbCtD
Desvenlafaxine—CYP3A4—Triamcinolone—hematologic cancer	0.0178	0.0307	CbGbCtD
Desvenlafaxine—CYP3A4—Dasatinib—hematologic cancer	0.0173	0.0299	CbGbCtD
Desvenlafaxine—CYP3A4—Mitoxantrone—hematologic cancer	0.0171	0.0295	CbGbCtD
Desvenlafaxine—CYP3A4—Betamethasone—hematologic cancer	0.0153	0.0263	CbGbCtD
Desvenlafaxine—CYP3A4—Prednisolone—hematologic cancer	0.0151	0.026	CbGbCtD
Desvenlafaxine—CYP3A4—Prednisone—hematologic cancer	0.0142	0.0245	CbGbCtD
Desvenlafaxine—CYP3A4—Irinotecan—hematologic cancer	0.0135	0.0232	CbGbCtD
Desvenlafaxine—CYP3A4—Vinblastine—hematologic cancer	0.012	0.0207	CbGbCtD
Desvenlafaxine—CYP3A4—Vincristine—hematologic cancer	0.0118	0.0203	CbGbCtD
Desvenlafaxine—CYP3A4—Etoposide—hematologic cancer	0.0108	0.0186	CbGbCtD
Desvenlafaxine—CYP3A4—Dexamethasone—hematologic cancer	0.00887	0.0153	CbGbCtD
Desvenlafaxine—CYP3A4—Doxorubicin—hematologic cancer	0.00736	0.0127	CbGbCtD
Desvenlafaxine—Venlafaxine—ABCG2—hematologic cancer	0.0016	0.706	CrCbGaD
Desvenlafaxine—Venlafaxine—ABCB1—hematologic cancer	0.000665	0.294	CrCbGaD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—hematologic cancer	0.000488	0.035	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—hematologic cancer	0.000477	0.0342	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—hematologic cancer	0.000399	0.0286	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.000357	0.0256	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNFRSF11B—hematologic cancer	0.000356	0.0255	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Amine compound SLC transporters—SLC22A1—hematologic cancer	0.000331	0.0237	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNFRSF11B—hematologic cancer	0.000306	0.022	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.000282	0.0203	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	0.000266	0.0191	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.000248	0.0178	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Serotonin Transporter Activity—IL1B—hematologic cancer	0.000243	0.0174	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PER3—hematologic cancer	0.000221	0.0159	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TCF3—hematologic cancer	0.000196	0.014	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PER2—hematologic cancer	0.000188	0.0135	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CRY2—hematologic cancer	0.000188	0.0135	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CRY1—hematologic cancer	0.000188	0.0135	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—GATA2—hematologic cancer	0.000181	0.013	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—UGT1A1—hematologic cancer	0.00017	0.0122	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hematologic cancer	0.000166	0.0119	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TSC2—hematologic cancer	0.000166	0.0119	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—ID3—hematologic cancer	0.00016	0.0115	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—RET—hematologic cancer	0.00016	0.0115	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—MAPK14—hematologic cancer	0.000158	0.0113	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—hematologic cancer	0.000155	0.0111	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	0.000155	0.0111	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—ABCG2—hematologic cancer	0.000147	0.0106	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	0.000144	0.0103	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TSC2—hematologic cancer	0.000143	0.0102	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—KMT2A—hematologic cancer	0.000143	0.0102	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PER1—hematologic cancer	0.000143	0.0102	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—UGT1A1—hematologic cancer	0.000139	0.00996	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—MAPK14—hematologic cancer	0.000136	0.00974	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TOP1—hematologic cancer	0.00013	0.00935	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000129	0.00928	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—ID2—hematologic cancer	0.000127	0.00911	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Farnesoid X Receptor  Pathway—FGF19—hematologic cancer	0.000125	0.00897	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—ABCC3—hematologic cancer	0.000119	0.00851	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TXN—hematologic cancer	0.000119	0.00851	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	0.000112	0.00807	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000112	0.00806	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—UGT1A1—hematologic cancer	0.000112	0.008	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	0.000109	0.00781	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	0.000108	0.00774	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—MYB—hematologic cancer	0.000104	0.00745	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—IL1B—hematologic cancer	0.000103	0.00742	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TXN—hematologic cancer	0.000102	0.00732	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—ABCC3—hematologic cancer	0.000102	0.00732	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—ARNTL—hematologic cancer	0.000102	0.00728	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	9.97e-05	0.00716	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—UGT1A1—hematologic cancer	9.59e-05	0.00688	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	9.51e-05	0.00683	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	9.32e-05	0.00668	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—IL1B—hematologic cancer	8.9e-05	0.00638	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	8.89e-05	0.00638	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL13—hematologic cancer	8.88e-05	0.00637	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	8.88e-05	0.00637	CbGpPWpGaD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	8.87e-05	0.000219	CcSEcCtD
Desvenlafaxine—Vomiting—Ifosfamide—hematologic cancer	8.85e-05	0.000219	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Cisplatin—hematologic cancer	8.85e-05	0.000219	CcSEcCtD
Desvenlafaxine—Tachycardia—Betamethasone—hematologic cancer	8.83e-05	0.000219	CcSEcCtD
Desvenlafaxine—Tachycardia—Dexamethasone—hematologic cancer	8.83e-05	0.000219	CcSEcCtD
Desvenlafaxine—Headache—Alitretinoin—hematologic cancer	8.83e-05	0.000218	CcSEcCtD
Desvenlafaxine—Angioedema—Prednisone—hematologic cancer	8.83e-05	0.000218	CcSEcCtD
Desvenlafaxine—Diarrhoea—Gemcitabine—hematologic cancer	8.81e-05	0.000218	CcSEcCtD
Desvenlafaxine—Nausea—Thalidomide—hematologic cancer	8.8e-05	0.000218	CcSEcCtD
Desvenlafaxine—Rash—Ifosfamide—hematologic cancer	8.78e-05	0.000217	CcSEcCtD
Desvenlafaxine—Dermatitis—Ifosfamide—hematologic cancer	8.77e-05	0.000217	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Methotrexate—hematologic cancer	8.77e-05	0.000217	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	8.76e-05	0.00629	CbGpPWpGaD
Desvenlafaxine—Hyperhidrosis—Dexamethasone—hematologic cancer	8.75e-05	0.000217	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Betamethasone—hematologic cancer	8.75e-05	0.000217	CcSEcCtD
Desvenlafaxine—Dizziness—Irinotecan—hematologic cancer	8.74e-05	0.000216	CcSEcCtD
Desvenlafaxine—Vertigo—Prednisone—hematologic cancer	8.68e-05	0.000215	CcSEcCtD
Desvenlafaxine—Eye disorder—Methotrexate—hematologic cancer	8.67e-05	0.000214	CcSEcCtD
Desvenlafaxine—Syncope—Prednisone—hematologic cancer	8.66e-05	0.000214	CcSEcCtD
Desvenlafaxine—Tinnitus—Methotrexate—hematologic cancer	8.65e-05	0.000214	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—JUND—hematologic cancer	8.63e-05	0.00619	CbGpPWpGaD
Desvenlafaxine—Vomiting—Vincristine—hematologic cancer	8.63e-05	0.000214	CcSEcCtD
Desvenlafaxine—Asthenia—Cisplatin—hematologic cancer	8.61e-05	0.000213	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methotrexate—hematologic cancer	8.61e-05	0.000213	CcSEcCtD
Desvenlafaxine—Fatigue—Triamcinolone—hematologic cancer	8.6e-05	0.000213	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—hematologic cancer	8.57e-05	0.000212	CcSEcCtD
Desvenlafaxine—Rash—Vincristine—hematologic cancer	8.56e-05	0.000212	CcSEcCtD
Desvenlafaxine—Dermatitis—Vincristine—hematologic cancer	8.55e-05	0.000212	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Epirubicin—hematologic cancer	8.53e-05	0.000211	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—hematologic cancer	8.51e-05	0.00021	CcSEcCtD
Desvenlafaxine—Headache—Vincristine—hematologic cancer	8.51e-05	0.00021	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Prednisone—hematologic cancer	8.49e-05	0.00021	CcSEcCtD
Desvenlafaxine—Nausea—Carmustine—hematologic cancer	8.45e-05	0.000209	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—hematologic cancer	8.44e-05	0.000209	CcSEcCtD
Desvenlafaxine—Angiopathy—Methotrexate—hematologic cancer	8.41e-05	0.000208	CcSEcCtD
Desvenlafaxine—Vomiting—Irinotecan—hematologic cancer	8.41e-05	0.000208	CcSEcCtD
Desvenlafaxine—Vomiting—Mitoxantrone—hematologic cancer	8.41e-05	0.000208	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methotrexate—hematologic cancer	8.38e-05	0.000207	CcSEcCtD
Desvenlafaxine—Nausea—Alitretinoin—hematologic cancer	8.37e-05	0.000207	CcSEcCtD
Desvenlafaxine—Convulsion—Prednisone—hematologic cancer	8.37e-05	0.000207	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methotrexate—hematologic cancer	8.36e-05	0.000207	CcSEcCtD
Desvenlafaxine—Hypertension—Prednisone—hematologic cancer	8.34e-05	0.000206	CcSEcCtD
Desvenlafaxine—Rash—Irinotecan—hematologic cancer	8.34e-05	0.000206	CcSEcCtD
Desvenlafaxine—Rash—Mitoxantrone—hematologic cancer	8.34e-05	0.000206	CcSEcCtD
Desvenlafaxine—Dermatitis—Mitoxantrone—hematologic cancer	8.33e-05	0.000206	CcSEcCtD
Desvenlafaxine—Dermatitis—Irinotecan—hematologic cancer	8.33e-05	0.000206	CcSEcCtD
Desvenlafaxine—Chills—Methotrexate—hematologic cancer	8.32e-05	0.000206	CcSEcCtD
Desvenlafaxine—Headache—Mitoxantrone—hematologic cancer	8.28e-05	0.000205	CcSEcCtD
Desvenlafaxine—Headache—Irinotecan—hematologic cancer	8.28e-05	0.000205	CcSEcCtD
Desvenlafaxine—Nausea—Ifosfamide—hematologic cancer	8.27e-05	0.000205	CcSEcCtD
Desvenlafaxine—Diarrhoea—Cisplatin—hematologic cancer	8.21e-05	0.000203	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—hematologic cancer	8.21e-05	0.000203	CcSEcCtD
Desvenlafaxine—Anxiety—Prednisone—hematologic cancer	8.19e-05	0.000203	CcSEcCtD
Desvenlafaxine—Alopecia—Methotrexate—hematologic cancer	8.19e-05	0.000203	CcSEcCtD
Desvenlafaxine—Vomiting—Gemcitabine—hematologic cancer	8.19e-05	0.000203	CcSEcCtD
Desvenlafaxine—Insomnia—Betamethasone—hematologic cancer	8.19e-05	0.000203	CcSEcCtD
Desvenlafaxine—Insomnia—Dexamethasone—hematologic cancer	8.19e-05	0.000203	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	8.17e-05	0.000202	CcSEcCtD
Desvenlafaxine—Paraesthesia—Betamethasone—hematologic cancer	8.13e-05	0.000201	CcSEcCtD
Desvenlafaxine—Paraesthesia—Dexamethasone—hematologic cancer	8.13e-05	0.000201	CcSEcCtD
Desvenlafaxine—Mental disorder—Methotrexate—hematologic cancer	8.12e-05	0.000201	CcSEcCtD
Desvenlafaxine—Rash—Gemcitabine—hematologic cancer	8.12e-05	0.000201	CcSEcCtD
Desvenlafaxine—Dermatitis—Gemcitabine—hematologic cancer	8.11e-05	0.000201	CcSEcCtD
Desvenlafaxine—Eye disorder—Epirubicin—hematologic cancer	8.11e-05	0.000201	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Etoposide—hematologic cancer	8.1e-05	0.000201	CcSEcCtD
Desvenlafaxine—Tinnitus—Epirubicin—hematologic cancer	8.09e-05	0.0002	CcSEcCtD
Desvenlafaxine—Malnutrition—Methotrexate—hematologic cancer	8.07e-05	0.0002	CcSEcCtD
Desvenlafaxine—Headache—Gemcitabine—hematologic cancer	8.07e-05	0.0002	CcSEcCtD
Desvenlafaxine—Nausea—Vincristine—hematologic cancer	8.07e-05	0.0002	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—hematologic cancer	8.05e-05	0.000199	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—GATA3—hematologic cancer	8.01e-05	0.00575	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Prednisolone—hematologic cancer	7.99e-05	0.000198	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—hematologic cancer	7.93e-05	0.000196	CcSEcCtD
Desvenlafaxine—Dysgeusia—Methotrexate—hematologic cancer	7.91e-05	0.000196	CcSEcCtD
Desvenlafaxine—Asthenia—Etoposide—hematologic cancer	7.89e-05	0.000195	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—hematologic cancer	7.89e-05	0.000195	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—hematologic cancer	7.87e-05	0.000195	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—hematologic cancer	7.87e-05	0.000195	CcSEcCtD
Desvenlafaxine—Decreased appetite—Betamethasone—hematologic cancer	7.87e-05	0.000195	CcSEcCtD
Desvenlafaxine—Decreased appetite—Dexamethasone—hematologic cancer	7.87e-05	0.000195	CcSEcCtD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	7.86e-05	0.00564	CbGpPWpGaD
Desvenlafaxine—Nausea—Mitoxantrone—hematologic cancer	7.85e-05	0.000194	CcSEcCtD
Desvenlafaxine—Nausea—Irinotecan—hematologic cancer	7.85e-05	0.000194	CcSEcCtD
Desvenlafaxine—Immune system disorder—Epirubicin—hematologic cancer	7.84e-05	0.000194	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—hematologic cancer	7.82e-05	0.000194	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Betamethasone—hematologic cancer	7.81e-05	0.000193	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	7.81e-05	0.000193	CcSEcCtD
Desvenlafaxine—Fatigue—Dexamethasone—hematologic cancer	7.8e-05	0.000193	CcSEcCtD
Desvenlafaxine—Fatigue—Betamethasone—hematologic cancer	7.8e-05	0.000193	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—hematologic cancer	7.79e-05	0.000193	CcSEcCtD
Desvenlafaxine—Shock—Prednisone—hematologic cancer	7.76e-05	0.000192	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CST3—hematologic cancer	7.75e-05	0.00556	CbGpPWpGaD
Desvenlafaxine—Nervous system disorder—Prednisone—hematologic cancer	7.73e-05	0.000191	CcSEcCtD
Desvenlafaxine—Tachycardia—Prednisone—hematologic cancer	7.69e-05	0.00019	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—hematologic cancer	7.67e-05	0.00019	CcSEcCtD
Desvenlafaxine—Skin disorder—Prednisone—hematologic cancer	7.66e-05	0.000189	CcSEcCtD
Desvenlafaxine—Nausea—Gemcitabine—hematologic cancer	7.65e-05	0.000189	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—NQO1—hematologic cancer	7.64e-05	0.00548	CbGpPWpGaD
Desvenlafaxine—Vomiting—Cisplatin—hematologic cancer	7.63e-05	0.000189	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Prednisone—hematologic cancer	7.62e-05	0.000189	CcSEcCtD
Desvenlafaxine—Vision blurred—Methotrexate—hematologic cancer	7.61e-05	0.000188	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—hematologic cancer	7.6e-05	0.000188	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—hematologic cancer	7.59e-05	0.000188	CcSEcCtD
Desvenlafaxine—Rash—Cisplatin—hematologic cancer	7.57e-05	0.000187	CcSEcCtD
Desvenlafaxine—Dermatitis—Cisplatin—hematologic cancer	7.56e-05	0.000187	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—hematologic cancer	7.55e-05	0.000187	CcSEcCtD
Desvenlafaxine—Diarrhoea—Etoposide—hematologic cancer	7.53e-05	0.000186	CcSEcCtD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNF—hematologic cancer	7.51e-05	0.00539	CbGpPWpGaD
Desvenlafaxine—Eye disorder—Doxorubicin—hematologic cancer	7.5e-05	0.000186	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—hematologic cancer	7.49e-05	0.000185	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—hematologic cancer	7.45e-05	0.000184	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—hematologic cancer	7.41e-05	0.000183	CcSEcCtD
Desvenlafaxine—Dysgeusia—Epirubicin—hematologic cancer	7.4e-05	0.000183	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Triamcinolone—hematologic cancer	7.35e-05	0.000182	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—hematologic cancer	7.34e-05	0.000182	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PML—hematologic cancer	7.3e-05	0.00523	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	7.29e-05	0.00523	CbGpPWpGaD
Desvenlafaxine—Angiopathy—Doxorubicin—hematologic cancer	7.29e-05	0.00018	CcSEcCtD
Desvenlafaxine—Dizziness—Etoposide—hematologic cancer	7.27e-05	0.00018	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—hematologic cancer	7.25e-05	0.000179	CcSEcCtD
Desvenlafaxine—Vertigo—Methotrexate—hematologic cancer	7.25e-05	0.000179	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—hematologic cancer	7.24e-05	0.000179	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—hematologic cancer	7.2e-05	0.000178	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	7.19e-05	0.00516	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HSP90AA1—hematologic cancer	7.19e-05	0.00515	CbGpPWpGaD
Desvenlafaxine—Dizziness—Prednisolone—hematologic cancer	7.17e-05	0.000177	CcSEcCtD
Desvenlafaxine—Asthenia—Triamcinolone—hematologic cancer	7.16e-05	0.000177	CcSEcCtD
Desvenlafaxine—Nausea—Cisplatin—hematologic cancer	7.13e-05	0.000176	CcSEcCtD
Desvenlafaxine—Insomnia—Prednisone—hematologic cancer	7.13e-05	0.000176	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—hematologic cancer	7.12e-05	0.000176	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—hematologic cancer	7.1e-05	0.000176	CcSEcCtD
Desvenlafaxine—Paraesthesia—Prednisone—hematologic cancer	7.08e-05	0.000175	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—hematologic cancer	7.03e-05	0.000174	CcSEcCtD
Desvenlafaxine—Convulsion—Methotrexate—hematologic cancer	6.99e-05	0.000173	CcSEcCtD
Desvenlafaxine—Vomiting—Etoposide—hematologic cancer	6.99e-05	0.000173	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—hematologic cancer	6.99e-05	0.000173	CcSEcCtD
Desvenlafaxine—Rash—Etoposide—hematologic cancer	6.94e-05	0.000172	CcSEcCtD
Desvenlafaxine—Dermatitis—Etoposide—hematologic cancer	6.93e-05	0.000171	CcSEcCtD
Desvenlafaxine—Headache—Etoposide—hematologic cancer	6.89e-05	0.00017	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—hematologic cancer	6.86e-05	0.00017	CcSEcCtD
Desvenlafaxine—Decreased appetite—Prednisone—hematologic cancer	6.85e-05	0.00017	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—hematologic cancer	6.85e-05	0.000169	CcSEcCtD
Desvenlafaxine—Rash—Prednisolone—hematologic cancer	6.84e-05	0.000169	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	6.84e-05	0.00491	CbGpPWpGaD
Desvenlafaxine—Dermatitis—Prednisolone—hematologic cancer	6.83e-05	0.000169	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	6.83e-05	0.000169	CcSEcCtD
Desvenlafaxine—Fatigue—Prednisone—hematologic cancer	6.8e-05	0.000168	CcSEcCtD
Desvenlafaxine—Headache—Prednisolone—hematologic cancer	6.8e-05	0.000168	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—hematologic cancer	6.79e-05	0.000168	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—hematologic cancer	6.79e-05	0.000168	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—hematologic cancer	6.77e-05	0.000168	CcSEcCtD
Desvenlafaxine—Constipation—Prednisone—hematologic cancer	6.74e-05	0.000167	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	6.69e-05	0.0048	CbGpPWpGaD
Desvenlafaxine—Palpitations—Epirubicin—hematologic cancer	6.68e-05	0.000165	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TOP2A—hematologic cancer	6.67e-05	0.00479	CbGpPWpGaD
Desvenlafaxine—Loss of consciousness—Epirubicin—hematologic cancer	6.64e-05	0.000164	CcSEcCtD
Desvenlafaxine—Dizziness—Triamcinolone—hematologic cancer	6.6e-05	0.000163	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—hematologic cancer	6.59e-05	0.000163	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—NQO1—hematologic cancer	6.57e-05	0.00471	CbGpPWpGaD
Desvenlafaxine—Convulsion—Epirubicin—hematologic cancer	6.55e-05	0.000162	CcSEcCtD
Desvenlafaxine—Nausea—Etoposide—hematologic cancer	6.53e-05	0.000162	CcSEcCtD
Desvenlafaxine—Hypertension—Epirubicin—hematologic cancer	6.52e-05	0.000161	CcSEcCtD
Desvenlafaxine—Asthenia—Betamethasone—hematologic cancer	6.49e-05	0.000161	CcSEcCtD
Desvenlafaxine—Asthenia—Dexamethasone—hematologic cancer	6.49e-05	0.000161	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methotrexate—hematologic cancer	6.46e-05	0.00016	CcSEcCtD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNF—hematologic cancer	6.46e-05	0.00463	CbGpPWpGaD
Desvenlafaxine—Nausea—Prednisolone—hematologic cancer	6.44e-05	0.000159	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—hematologic cancer	6.41e-05	0.000159	CcSEcCtD
Desvenlafaxine—Skin disorder—Methotrexate—hematologic cancer	6.4e-05	0.000158	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.39e-05	0.000158	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTP1—hematologic cancer	6.37e-05	0.00457	CbGpPWpGaD
Desvenlafaxine—Hyperhidrosis—Methotrexate—hematologic cancer	6.37e-05	0.000158	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—AR—hematologic cancer	6.36e-05	0.00456	CbGpPWpGaD
Desvenlafaxine—Vomiting—Triamcinolone—hematologic cancer	6.34e-05	0.000157	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—EZH2—hematologic cancer	6.34e-05	0.00455	CbGpPWpGaD
Desvenlafaxine—Rash—Triamcinolone—hematologic cancer	6.29e-05	0.000156	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—hematologic cancer	6.29e-05	0.000156	CcSEcCtD
Desvenlafaxine—Dermatitis—Triamcinolone—hematologic cancer	6.28e-05	0.000155	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—hematologic cancer	6.28e-05	0.000155	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—hematologic cancer	6.27e-05	0.000155	CcSEcCtD
Desvenlafaxine—Headache—Triamcinolone—hematologic cancer	6.25e-05	0.000155	CcSEcCtD
Desvenlafaxine—Diarrhoea—Dexamethasone—hematologic cancer	6.19e-05	0.000153	CcSEcCtD
Desvenlafaxine—Diarrhoea—Betamethasone—hematologic cancer	6.19e-05	0.000153	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—HSP90AA1—hematologic cancer	6.18e-05	0.00443	CbGpPWpGaD
Desvenlafaxine—Palpitations—Doxorubicin—hematologic cancer	6.18e-05	0.000153	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—hematologic cancer	6.14e-05	0.000152	CcSEcCtD
Desvenlafaxine—Shock—Epirubicin—hematologic cancer	6.07e-05	0.00015	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—hematologic cancer	6.06e-05	0.00015	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Epirubicin—hematologic cancer	6.05e-05	0.00015	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—hematologic cancer	6.03e-05	0.000149	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—hematologic cancer	6.02e-05	0.000149	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—hematologic cancer	5.99e-05	0.000148	CcSEcCtD
Desvenlafaxine—Dizziness—Betamethasone—hematologic cancer	5.99e-05	0.000148	CcSEcCtD
Desvenlafaxine—Dizziness—Dexamethasone—hematologic cancer	5.99e-05	0.000148	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—HDAC2—hematologic cancer	5.98e-05	0.00429	CbGpPWpGaD
Desvenlafaxine—Hyperhidrosis—Epirubicin—hematologic cancer	5.96e-05	0.000147	CcSEcCtD
Desvenlafaxine—Insomnia—Methotrexate—hematologic cancer	5.96e-05	0.000147	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—hematologic cancer	5.93e-05	0.000147	CcSEcCtD
Desvenlafaxine—Nausea—Triamcinolone—hematologic cancer	5.93e-05	0.000147	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methotrexate—hematologic cancer	5.92e-05	0.000146	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.91e-05	0.000146	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	5.88e-05	0.00422	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HGF—hematologic cancer	5.86e-05	0.0042	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTM1—hematologic cancer	5.86e-05	0.0042	CbGpPWpGaD
Desvenlafaxine—Somnolence—Methotrexate—hematologic cancer	5.86e-05	0.000145	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—hematologic cancer	5.82e-05	0.000144	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Prednisone—hematologic cancer	5.81e-05	0.000144	CcSEcCtD
Desvenlafaxine—Vomiting—Dexamethasone—hematologic cancer	5.76e-05	0.000142	CcSEcCtD
Desvenlafaxine—Vomiting—Betamethasone—hematologic cancer	5.76e-05	0.000142	CcSEcCtD
Desvenlafaxine—Decreased appetite—Methotrexate—hematologic cancer	5.73e-05	0.000142	CcSEcCtD
Desvenlafaxine—Rash—Dexamethasone—hematologic cancer	5.71e-05	0.000141	CcSEcCtD
Desvenlafaxine—Rash—Betamethasone—hematologic cancer	5.71e-05	0.000141	CcSEcCtD
Desvenlafaxine—Dermatitis—Betamethasone—hematologic cancer	5.7e-05	0.000141	CcSEcCtD
Desvenlafaxine—Dermatitis—Dexamethasone—hematologic cancer	5.7e-05	0.000141	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.69e-05	0.000141	CcSEcCtD
Desvenlafaxine—Fatigue—Methotrexate—hematologic cancer	5.68e-05	0.000141	CcSEcCtD
Desvenlafaxine—Headache—Betamethasone—hematologic cancer	5.67e-05	0.00014	CcSEcCtD
Desvenlafaxine—Headache—Dexamethasone—hematologic cancer	5.67e-05	0.00014	CcSEcCtD
Desvenlafaxine—Asthenia—Prednisone—hematologic cancer	5.66e-05	0.00014	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	5.65e-05	0.00405	CbGpPWpGaD
Desvenlafaxine—Shock—Doxorubicin—hematologic cancer	5.61e-05	0.000139	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—hematologic cancer	5.59e-05	0.000138	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HES1—hematologic cancer	5.59e-05	0.00401	CbGpPWpGaD
Desvenlafaxine—Insomnia—Epirubicin—hematologic cancer	5.58e-05	0.000138	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—hematologic cancer	5.57e-05	0.000138	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL10—hematologic cancer	5.56e-05	0.00399	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	5.55e-05	0.00398	CbGpPWpGaD
Desvenlafaxine—Skin disorder—Doxorubicin—hematologic cancer	5.54e-05	0.000137	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—hematologic cancer	5.54e-05	0.000137	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—hematologic cancer	5.51e-05	0.000136	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTP1—hematologic cancer	5.48e-05	0.00393	CbGpPWpGaD
Desvenlafaxine—Somnolence—Epirubicin—hematologic cancer	5.48e-05	0.000136	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	5.45e-05	0.00391	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Prednisone—hematologic cancer	5.39e-05	0.000133	CcSEcCtD
Desvenlafaxine—Nausea—Betamethasone—hematologic cancer	5.38e-05	0.000133	CcSEcCtD
Desvenlafaxine—Nausea—Dexamethasone—hematologic cancer	5.38e-05	0.000133	CcSEcCtD
Desvenlafaxine—Decreased appetite—Epirubicin—hematologic cancer	5.36e-05	0.000133	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	5.35e-05	0.00384	CbGpPWpGaD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.32e-05	0.000132	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—hematologic cancer	5.32e-05	0.000132	CcSEcCtD
Desvenlafaxine—Constipation—Epirubicin—hematologic cancer	5.27e-05	0.00013	CcSEcCtD
Desvenlafaxine—Dizziness—Prednisone—hematologic cancer	5.21e-05	0.000129	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—hematologic cancer	5.16e-05	0.000128	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	5.14e-05	0.00369	CbGpPWpGaD
Desvenlafaxine—Paraesthesia—Doxorubicin—hematologic cancer	5.12e-05	0.000127	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—hematologic cancer	5.07e-05	0.000125	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	5.07e-05	0.00364	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—PDGFB—hematologic cancer	5.04e-05	0.00361	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HGF—hematologic cancer	5.04e-05	0.00361	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTM1—hematologic cancer	5.04e-05	0.00361	CbGpPWpGaD
Desvenlafaxine—Vomiting—Prednisone—hematologic cancer	5.01e-05	0.000124	CcSEcCtD
Desvenlafaxine—Rash—Prednisone—hematologic cancer	4.97e-05	0.000123	CcSEcCtD
Desvenlafaxine—Dermatitis—Prednisone—hematologic cancer	4.97e-05	0.000123	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—hematologic cancer	4.96e-05	0.000123	CcSEcCtD
Desvenlafaxine—Headache—Prednisone—hematologic cancer	4.94e-05	0.000122	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.93e-05	0.000122	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—hematologic cancer	4.92e-05	0.000122	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—hematologic cancer	4.88e-05	0.000121	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methotrexate—hematologic cancer	4.85e-05	0.00012	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	4.77e-05	0.00342	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	4.74e-05	0.0034	CbGpPWpGaD
Desvenlafaxine—Asthenia—Methotrexate—hematologic cancer	4.73e-05	0.000117	CcSEcCtD
Desvenlafaxine—Nausea—Prednisone—hematologic cancer	4.68e-05	0.000116	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Epirubicin—hematologic cancer	4.54e-05	0.000112	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NCOR1—hematologic cancer	4.54e-05	0.00325	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	4.52e-05	0.00324	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	4.52e-05	0.00324	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Methotrexate—hematologic cancer	4.51e-05	0.000112	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	4.49e-05	0.00322	CbGpPWpGaD
Desvenlafaxine—Asthenia—Epirubicin—hematologic cancer	4.42e-05	0.000109	CcSEcCtD
Desvenlafaxine—Dizziness—Methotrexate—hematologic cancer	4.36e-05	0.000108	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—PDGFB—hematologic cancer	4.33e-05	0.00311	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PRKCG—hematologic cancer	4.33e-05	0.00311	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Epirubicin—hematologic cancer	4.22e-05	0.000104	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—hematologic cancer	4.2e-05	0.000104	CcSEcCtD
Desvenlafaxine—Vomiting—Methotrexate—hematologic cancer	4.19e-05	0.000104	CcSEcCtD
Desvenlafaxine—Rash—Methotrexate—hematologic cancer	4.15e-05	0.000103	CcSEcCtD
Desvenlafaxine—Dermatitis—Methotrexate—hematologic cancer	4.15e-05	0.000103	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	4.13e-05	0.00296	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	4.13e-05	0.00296	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	4.13e-05	0.00296	CbGpPWpGaD
Desvenlafaxine—Headache—Methotrexate—hematologic cancer	4.13e-05	0.000102	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—hematologic cancer	4.09e-05	0.000101	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—hematologic cancer	4.08e-05	0.000101	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—FAS—hematologic cancer	4.07e-05	0.00292	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CREB1—hematologic cancer	3.93e-05	0.00282	CbGpPWpGaD
Desvenlafaxine—Vomiting—Epirubicin—hematologic cancer	3.92e-05	9.7e-05	CcSEcCtD
Desvenlafaxine—Nausea—Methotrexate—hematologic cancer	3.91e-05	9.68e-05	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—hematologic cancer	3.9e-05	9.66e-05	CcSEcCtD
Desvenlafaxine—Rash—Epirubicin—hematologic cancer	3.89e-05	9.62e-05	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—hematologic cancer	3.88e-05	9.61e-05	CcSEcCtD
Desvenlafaxine—Headache—Epirubicin—hematologic cancer	3.86e-05	9.56e-05	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6R—hematologic cancer	3.83e-05	0.00275	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	3.82e-05	0.00274	CbGpPWpGaD
Desvenlafaxine—Dizziness—Doxorubicin—hematologic cancer	3.77e-05	9.33e-05	CcSEcCtD
Desvenlafaxine—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	3.77e-05	0.0027	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	3.72e-05	0.00267	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	3.71e-05	0.00266	CbGpPWpGaD
Desvenlafaxine—Nausea—Epirubicin—hematologic cancer	3.66e-05	9.06e-05	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—hematologic cancer	3.63e-05	8.97e-05	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—hematologic cancer	3.6e-05	8.9e-05	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—hematologic cancer	3.59e-05	8.89e-05	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CDK4—hematologic cancer	3.58e-05	0.00257	CbGpPWpGaD
Desvenlafaxine—Headache—Doxorubicin—hematologic cancer	3.57e-05	8.84e-05	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—hematologic cancer	3.39e-05	8.38e-05	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	3.27e-05	0.00234	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CREB1—hematologic cancer	3.21e-05	0.0023	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.99e-05	0.00214	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—hematologic cancer	2.91e-05	0.00209	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—hematologic cancer	2.91e-05	0.00209	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—JUN—hematologic cancer	2.82e-05	0.00203	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.82e-05	0.00202	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.74e-05	0.00196	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.72e-05	0.00195	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.66e-05	0.00191	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—EP300—hematologic cancer	2.6e-05	0.00187	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	2.47e-05	0.00177	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	2.43e-05	0.00174	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	2.39e-05	0.00172	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFB1—hematologic cancer	2.39e-05	0.00171	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.37e-05	0.0017	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—JUN—hematologic cancer	2.31e-05	0.00165	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	2.28e-05	0.00164	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	2.25e-05	0.00161	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PTEN—hematologic cancer	2.23e-05	0.0016	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—MAPK8—hematologic cancer	2.18e-05	0.00156	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—EP300—hematologic cancer	2.13e-05	0.00153	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—hematologic cancer	2.11e-05	0.00152	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB1—hematologic cancer	2.05e-05	0.00147	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.05e-05	0.00147	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	2.01e-05	0.00144	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.99e-05	0.00143	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.98e-05	0.00142	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.88e-05	0.00135	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.71e-05	0.00122	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.66e-05	0.00119	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TP53—hematologic cancer	1.52e-05	0.00109	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—IL6—hematologic cancer	1.39e-05	0.000999	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.3e-05	0.000936	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.29e-05	0.000923	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.2e-05	0.00086	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.18e-05	0.000848	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.11e-05	0.000797	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.04e-05	0.000746	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PHYH—hematologic cancer	9.99e-06	0.000717	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GMPS—hematologic cancer	9.99e-06	0.000717	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—FTCD—hematologic cancer	9.99e-06	0.000717	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SMPD3—hematologic cancer	9.14e-06	0.000656	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—DCK—hematologic cancer	7.99e-06	0.000573	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ASNS—hematologic cancer	7.99e-06	0.000573	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.99e-06	0.000573	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HDC—hematologic cancer	7.57e-06	0.000543	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CDA—hematologic cancer	6.93e-06	0.000497	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PC—hematologic cancer	6.67e-06	0.000478	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GBA—hematologic cancer	6.44e-06	0.000462	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.44e-06	0.000462	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTAP—hematologic cancer	5.89e-06	0.000423	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—FHL2—hematologic cancer	5.25e-06	0.000377	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AGRN—hematologic cancer	5.15e-06	0.000369	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMMR—hematologic cancer	4.88e-06	0.00035	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—IDH2—hematologic cancer	4.88e-06	0.00035	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.59e-06	0.000329	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ACP5—hematologic cancer	4.46e-06	0.00032	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CA9—hematologic cancer	4.46e-06	0.00032	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.41e-06	0.000316	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—IDH1—hematologic cancer	4.2e-06	0.000301	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.15e-06	0.000298	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TXN—hematologic cancer	4.15e-06	0.000298	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.15e-06	0.000298	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.06e-06	0.000291	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.9e-06	0.00028	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.8e-06	0.000272	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.8e-06	0.000272	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.7e-06	0.000265	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.58e-06	0.000257	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.48e-06	0.000249	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.48e-06	0.000249	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NUP214—hematologic cancer	3.45e-06	0.000248	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTR—hematologic cancer	3.38e-06	0.000243	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.38e-06	0.000243	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ENO2—hematologic cancer	3.32e-06	0.000238	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.22e-06	0.000231	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.15e-06	0.000226	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CD44—hematologic cancer	2.67e-06	0.000192	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.67e-06	0.000192	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.53e-06	0.000182	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.51e-06	0.00018	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.23e-06	0.00016	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.11e-06	0.000151	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.05e-06	0.000147	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.05e-06	0.000147	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.81e-06	0.00013	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.52e-06	0.000109	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.41e-06	0.000101	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.34e-06	9.6e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALB—hematologic cancer	1.32e-06	9.48e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.26e-06	9.06e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.17e-06	8.37e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.01e-06	7.23e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—EP300—hematologic cancer	9.61e-07	6.89e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.11e-07	5.1e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKT1—hematologic cancer	5.81e-07	4.17e-05	CbGpPWpGaD
